Comments
Loading...
Vitamin Blue Analyst Ratings and Price Targets | OTC:VTMB | Benzinga
Vitamin Blue Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Vitamin Blue Corp from these most-recent analyst ratings.
Analyst Ratings for Vitamin Blue
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Vitamin Blue (VTMB) stock?
There is no price target for Vitamin Blue
What is the most recent analyst rating for Vitamin Blue (VTMB)?
There is no analyst for Vitamin Blue
When was the last upgrade for Vitamin Blue (VTMB)?
There is no last upgrade for Vitamin Blue
When was the last downgrade for Vitamin Blue (VTMB)?
There is no last downgrade for Vitamin Blue.
When is the next analyst rating going to be posted or updated for Vitamin Blue (VTMB)?
There is no next analyst rating for Vitamin Blue.
Is the Analyst Rating Vitamin Blue (VTMB) correct?
There is no next analyst rating for Vitamin Blue.
Browse analyst ratings and price targets on all stocks.
